March 5, 2020 / 6:12 AM / a month ago

BRIEF-Newron Pharmaceuticals FY Net Loss Widens To EUR 20.2 Million

March 5 (Reuters) - Newron Pharmaceuticals SpA:

* NEWRON PHARMACEUTICALS SPA - IN 2019, NEWRON REPORTED A NET LOSS OF EUR 20.2 MILLION, COMPARED TO EUR 15.0 MILLION IN 2018. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below